Olaplex Investor Presentation Deck

2023 REPRESENTS A RESET YEAR TO INCREASE INVESTMENTS TO SUPPORT FUTURE GROWTH Net Sales Adjusted Net Income* Adjusted EBITDA* FY 2023 Guidance $563 - $634 MM $176 - $224 MM $261 - $322 MM Q1 2023 13 . ● ● Continuation of negative impacts from inventory rebalancing at certain Pro and Specialty Retail customers of approx. $25 MM Q2 2023 Lapping approx. $22 MM in net sales from the introduction of 1-liter offerings in Q2 2022 Lapping approx. $10 MM in net sales from Ulta pipeline shipments in Q2 2022 ● Lapping approx. $10 MM in net sales from pull-forward demand related to July 2022 price increase 2H 2023 Benefit of new product introductions and distribution gains Improvement in demand from increased sales, marketing and education investments *Adjusted EBITDA and Adjusted Net Income are non-GAAP measures. The Company is not able to provide, without unreasonable effort, a reconciliation of the guidance for adjusted EBITDA and adjusted net income to the most directly comparable GAAP measure because the Company does not currently have sufficient data to accurately estimate the variables and individual adjustments included in the most directly comparable GAAP measure that would be nece ary for such reconciliations, including (a) income tax related accruals in respect of certain one-time items, (b) costs related to potential debt or equity transactions, and (c) other non-recurring expenses that cannot reasonably be estimated in advance. These adjustments are inherently variable and uncertain and depend on various factors that are beyond the Company's control and as a result it is also unable to predict their probable significance. Therefore, because management cannot estimate on a forward-looking basis without unreasonable effort the impact these variables and individual adjustments will have on its reported results in accordance with GAAP, it is unable to provide a reconciliation of the non-GAAP measures included in its fiscal 2023 guidance. OLAPLEX

View entire presentation